- Home
- MYGN vs BKE Comparison
MYGN vs BKE Comparison
Compare MYGN & BKE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MYGN
- BKE
- Stock Information
- Founded
- MYGN 1991
- BKE 1948
- Country
- MYGN United States
- BKE United States
- Employees
- MYGN N/A
- BKE N/A
- Industry
- MYGN Biotechnology: In Vitro & In Vivo Diagnostic Substances
- BKE Clothing/Shoe/Accessory Stores
- Sector
- MYGN Health Care
- BKE Consumer Discretionary
- Exchange
- MYGN Nasdaq
- BKE Nasdaq
- Market Cap
- MYGN 2.0B
- BKE 2.6B
- IPO Year
- MYGN 1995
- BKE 1992
- Fundamental
- Price
- MYGN $13.36
- BKE $50.87
- Analyst Decision
- MYGN Hold
- BKE Hold
- Analyst Count
- MYGN 12
- BKE 1
- Target Price
- MYGN $23.92
- BKE $46.00
- AVG Volume (30 Days)
- MYGN 1.1M
- BKE 529.6K
- Earning Date
- MYGN 11-07-2024
- BKE 11-22-2024
- Dividend Yield
- MYGN N/A
- BKE 7.67%
- EPS Growth
- MYGN N/A
- BKE N/A
- EPS
- MYGN N/A
- BKE 3.94
- Revenue
- MYGN $823,600,000.00
- BKE $1,220,873,000.00
- Revenue This Year
- MYGN $13.82
- BKE N/A
- Revenue Next Year
- MYGN $4.59
- BKE $2.38
- P/E Ratio
- MYGN N/A
- BKE $12.93
- Revenue Growth
- MYGN 12.15
- BKE N/A
- 52 Week Low
- MYGN $12.87
- BKE $34.87
- 52 Week High
- MYGN $29.30
- BKE $54.25
- Technical
- Relative Strength Index (RSI)
- MYGN 26.22
- BKE 52.39
- Support Level
- MYGN $12.87
- BKE $49.21
- Resistance Level
- MYGN $15.44
- BKE $52.64
- Average True Range (ATR)
- MYGN 0.84
- BKE 1.45
- MACD
- MYGN -0.02
- BKE -0.54
- Stochastic Oscillator
- MYGN 12.37
- BKE 32.94
About MYGN Myriad Genetics Inc.
Myriad Genetics is a molecular diagnostics company that provides testing services designed to assess an individual's risk of developing a disease. The firm produces MyRisk, a 48-gene panel with the capability to identify the elevated risk of developing 11 types of cancer. Other diagnostic products include BRACAnalysis CDx, the FDA-approved companion diagnostic for PARP inhibitors; GeneSight, which helps improve responses to psychotropic drugs for patients suffering from depression; and Prequel, a noninvasive prenatal test. Precise Oncology Solutions, launched in 2022, combines Precise Tumor with companion diagnostic and prognostic tests such as MyChoice CDx, Prolaris, and EndoPredict. The firm offers biomarker discovery and companion diagnostic services to pharma and biotech companies.
About BKE Buckle Inc. (The)
Buckle Inc is a retailer of casual apparel, footwear, and accessories. The company retails medium to better-priced casual apparel, footwear, and accessories for fashion-conscious young men and women. It retails under the brand names 'Buckle' and 'The Buckle'. Buckle markets a wide selection of mostly brand-name casual apparel including denim, other casual bottoms, tops, sportswear, outerwear, accessories, and footwear.